Startups channel feed – Endpoints News

Startups channel feed

Rising Penn star Saar Gill gets funding for a next-gen CAR-T startup, adding a new weapon to the mix

8 years ago

BRIEF: Deciphera bags a $52M round to back its cancer drug pipeline work

8 years ago

Bicycle Therapeutics banks a $52M B round for the next leg of the long R&D journey ahead

8 years ago

China biotech startup InventisBio bags a $19M round for early-stage R&D

8 years ago

Eli Lilly-backed Symic raises $30M round as it preps for a pivotal trial

9 years ago

Two R&D pros map a PhIII game plan with $65M round and a castoff from Pfizer

9 years ago

After a bruising turn as Sarepta CEO, Chris Garabedian is back in biotech with a new role as godfather to a bunch of startups

9 years ago

Armed with a $435M bankroll, Polaris looks to the next wave of biotech startups

9 years ago

Five months, $98.5M and a PhII drug from Novartis later, Magenta Therapeutics is flooring it

9 years ago

Neil Kumar's BridgeBio lines up subsidiary No. 9 with a $27M shot at TTR amyloidosis

9 years ago

Chalk up one more biotech startup for MIT’s Bob Langer

9 years ago

A serial biotech startup team is back in business, armed with $40M and a focus on NASH

9 years ago

Frequency Therapeutics gets a $32M startup round to help fine tune its hearing loss drug R&D

9 years ago

Novartis finds its next mass-market ophthalmology drug candidate at a small virtual biotech with a global view

9 years ago

Takeda partners with an upstart drugs-from-bugs microbiome player inspired by a fecal transplantation biz

9 years ago

Small biotech — big ambitions. Viralytics’ oncolytics therapy makes the showcase round at #AACR17 with positive combo snapshot

9 years ago

Money, brains and ambition: Third Rock startup Tango launches with $55M and a stellar crew of scientific advisers

9 years ago

Novartis research leader takes the helm at Forty Seven, a CIRM-backed fledgling already deep in the clinic

9 years ago

Google’s venture arm leads Spero’s $51.7M round for R&D work on a pipeline of new antibiotics

9 years ago

High-profile biotech leader Deborah Dunsire takes the helm at XTuit, focused on cancer and fibrosis

9 years ago

Biotech spinout grabs $46M round, jumps straight into PhIII with a drug/device combo for rare lung condition

9 years ago

A CRISPR/Cas9 startup launches on the R&D frontier, working on a one-time fix for Duchenne MD

9 years ago

Going big: Biotech vets blast off with Arrakis on a new journey of RNA exploration

9 years ago

PMV Pharma gets a whopping $74M round to test a new p53 drug in humans

9 years ago

First page Previous page 69 70 717273 74 Next page Last page